From: Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients
SA-AIP | L-AIP | p value | |
---|---|---|---|
N (%) | 27 (49.1 %) | 28 (50.9 %) | – |
Age (mean ± SD) | 47.5 ± 15.6 | 41.3 ± 15.7 | – |
Age range (years) | [28–77] | [16–75] | – |
Females, N (%) | 20 (74.1 %) | 12 (42.8 %) | – |
Males, N (%) | 7 (25.9 %) | 18 (57.1 %) | – |
c.669_698del30 carriersa, N (%) | 20 (74.1 %) | 24 (85.7 %) | – |
BMI (mean ± SD) | 26.93 ± 4.4 | 28.17 ± 4.93 | 0.3436 |
Biochemical assessments (mean ± SD) | |||
eGFR (ml/min per 1.73m2) | 73.16 ± 27.3 | 105.07 ± 19.2 | < 0.0001* |
AST (U/L) | 28.19 ± 6.5 | 22.31 ± 8.6 | 0.0082* |
ALT (U/L) | 27.04 ± 14.4 | 25.3 ± 10.8 | 0.6119 |
GGT (U/L) | 20.24 ± 18.5 | 26.52 ± 17.6 | 0.3047 |
Hb in males (g/dl) | 13.54 ± 1.73 | 14.4 ± 1.36 | 0.0563 |
Ferritin in males (ng/ml) | 57.59 ± 64.26 | 80.46 ± 65.08 | 0.2373 |
Hb in females (g/dl) | 12.64 ± 0.89 | 13.34 ± 0.95 | 0.1270 |
Ferritin in females (ng/ml) | 53.44 ± 37.5 | 43.73 ± 68.7 | 0.6513 |
U-PBG/Crb (µmol /mmol) | 17.09 ± 15.93 | 1.32 ± 2.29 | 0.0001* |
U-ALA/Crb (µmol /mmol) | 9.86 ± 6.76 | 6.06 ± 4.35 | 0.1333 |
HRQoL scores (mean ± SD) | |||
EQ-5D-5L index | 0.809 ± 0.16 | 0.926 ± 0.14 | 0.0497* |
EQ-5D-5L VAS | 75.44 ± 16.16 | 86.78 ± 15.78 | 0.1353 |